Cargando…
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study
BACKGROUND/AIM: Studies regarding effectiveness of anakinra and tocilizumab treatments in coronavirus disease 2019 (COVID-19) have contradictory results. Furthermore, there is scarce comparative data regarding superiority of any agent. To further elucidate any superiority between these two agents, w...
Autores principales: | KÜÇÜKŞAHİN, Orhan, ERDEN, Abdulsamet, KARAKAŞ, Özlem, GÜVEN, Serdar Can, ARMAĞAN, Berkan, ŞAHİNER, Enes Seyda, İNAN, Osman, KURTİPEK, Ali Can, GEMCİOĞLU, Emin, KARAAHMETOĞLU, Selma, TURAN, Sema, İZDEŞ, Seval, ERDEM, Deniz, AYPAK, Adalet, AYHAN, Müge, AKINCI, Esragül, BODUR, Hürrem, GÜNER, Rahmet, OMMA, Ahmet, ATEŞ, İhsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395730/ https://www.ncbi.nlm.nih.gov/pubmed/36422492 http://dx.doi.org/10.55730/1300-0144.5487 |
Ejemplares similares
-
A single center experience of intravenous immunoglobulin treatment in Covid-19
por: Omma, Ahmet, et al.
Publicado: (2021) -
COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study
por: Güven, Serdar Can, et al.
Publicado: (2021) -
The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases
por: Erden, Abdulsamet, et al.
Publicado: (2023) -
False positivity of Rose Bengal test in patients with COVID-19: case series, uncontrolled longitudinal study
por: Gemcioglu, Emin, et al.
Publicado: (2020) -
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir
por: Guner, Rahmet, et al.
Publicado: (2021)